ORGANOGENESIS HOLDINGS INC.

Analyst Reco. Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq Other stock markets 01:30:00 14/05/2024 am IST			5-day change	1st Jan Change
2.96 ^USD	-2.31%		+23.85%	-27.63%

13/05	Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating	MT
10/05	Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating	13/05	MT
BTIG Raises Price Target on Organogenesis Holdings to $6 From $4, Keeps Buy Rating	27/12	MT
Morgan Stanley Adjusts Price Target on Organogenesis to $3.50 From $3, Maintains Equalweight Rating	14/11	MT
Hopes of rate peak, China turnaround lift stocks	04/23/04	AN
Morgan Stanley Adjusts Price Target on Organogenesis Holdings to $3 From $5, Maintains Equal-Weight Rating	11/23/11	MT
Morgan Stanley Starts Organogenesis Holdings at Equalweight With $5 Price Target	15/23/15	MT
BTIG Upgrades Organogenesis to Buy From Neutral, Price Target is $10	24/23/24	MT
BTIG Downgrades Organogenesis Holdings to Neutral From Buy	10/22/10	MT
Oppenheimer Downgrades Organogenesis Holdings to Perform From Outperform, Removes $14 Price Target	10/22/10	MT
SVB Leerink Adjusts Organogenesis Holdings' Price Target to $20 from $26, Keeps Outperform Rating	11/21/11	MT
ORGANOGENESIS : Oppenheimer Adjusts Organogenesis Holdings PT to $28 From $25 on Strong Q1 Beat and Raised Guidance, Maintains Outperform Rating	11/21/11	MT
ORGANOGENESIS : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $25 From $21, Keeps Outperform Rating	21/21/21	MT
ORGANOGENESIS : SVB Leerink Adjusts Price Target on Organogenesis Holdings to $22 From $19, Maintains Outperform Rating	17/21/17	MT
ORGANOGENESIS : Credit Suisse Raises Organogenesis Holdings' PT to $21 from $9, Expects Continued Success of Commercial Execution Strategy; Keeps Outperform Rating	12/21/12	MT
ORGANOGENESIS : SVB Leerink Adjusts Organogenesis Holdings' Price Target to $13 From $10, Keeps at Outperform	20/21/20	MT
ORGANOGENESIS : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $13 From $9, Maintains Outperform Rating	15/21/15	MT
ORGANOGENESIS : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $9 from $8, Keeps Outperform Rating	07/21/07	MT
ORGANOGENESIS : SVB Leerink Adjusts Organogenesis Holdings' Price Target to $10 From $9, Keeps at Outperform	18/20/18	MT
ORGANOGENESIS : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $8 from $7, Keeps Outperform Rating	10/20/10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW